Authors:
Jacobs, JWG
Geenen, R
Evers, AWM
van Jaarsveld, CHM
Kraaimaat, FW
Bijlsma, JWJ
Citation: Jwg. Jacobs et al., Short term effects of corticosteroid pulse treatment on disease activity and the wellbeing of patients with active rheumatoid arthritis, ANN RHEUM D, 60(1), 2001, pp. 61-64
Authors:
van Jaarsveld, CHM
Sanderman, R
Miedema, I
Ranchor, AV
Kempen, GIJM
Citation: Chm. Van Jaarsveld et al., Changes in health-related quality of life in older patients with acute myocardial infarction or congestive heart failure: A prospective study, J AM GER SO, 49(8), 2001, pp. 1052-1058
Authors:
Kempen, GIJM
van Jaarsveld, CHM
van Sonderen, E
Sanderman, R
Ormel, J
Citation: Gijm. Kempen et al., Risk factors for developing cardiac disease in late middle-aged and older men and women: A prospective study, J AM GER SO, 49(11), 2001, pp. 1575-1577
Authors:
van Jaarsveld, CHM
Jahangier, ZN
Jacobs, JWG
Blaauw, AAM
van Albada-Kuipers, GA
ter Borg, EJ
Brus, HLM
Schenk, Y
van der Veen, MJ
Bijlsma, JWJ
Citation: Chm. Van Jaarsveld et al., Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis, RHEUMATOLOG, 39(12), 2000, pp. 1374-1382
Authors:
van Jaarsveld, CHM
Jacobs, JWG
van der Veen, MJ
Blaauw, AAM
Kruize, AA
Hofman, DM
Brus, HLM
van Albada-Kuipers, GA
Heurkens, AHM
ter Borg, EJ
Haanen, HCM
van Booma-Frankfort, C
Schenk, Y
Bijlsma, JWJ
Citation: Chm. Van Jaarsveld et al., Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial, ANN RHEUM D, 59(6), 2000, pp. 468-477
Authors:
van Jaarsveld, CHM
ter Borg, EJ
Jacobs, JWG
Schellekens, GA
Gmelig-Meyling, FHJ
van Booma-Frankfort, C
de Jong, BAW
van Venrooij, WJ
Bijlsma, JWJ
Citation: Chm. Van Jaarsveld et al., The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis, CLIN EXP RH, 17(6), 1999, pp. 689-697